As of 2026-03-20, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (3.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.12 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -129.6%.
The range of the Relative Valuation is (3.52) - (6.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.1x - 5.8x | 3.3x |
| Forward P/E multiples | 3.2x - 8.6x | 3.3x |
| Fair Price | (3.52) - (6.32) | (3.58) |
| Upside | -129.0% - -152.1% | -129.6% |
| Date | P/E |
| 2026-03-18 | -10.96 |
| 2026-03-17 | -11.48 |
| 2026-03-16 | -11.43 |
| 2026-03-13 | -11.99 |
| 2026-03-12 | -12.30 |
| 2026-03-11 | -12.97 |
| 2026-03-10 | -12.66 |
| 2026-03-09 | -12.24 |
| 2026-03-06 | -12.08 |
| 2026-03-05 | -12.16 |
| 2026-03-04 | -12.63 |
| 2026-03-03 | -12.38 |
| 2026-03-02 | -12.76 |
| 2026-02-27 | -12.83 |
| 2026-02-26 | -14.15 |
| 2026-02-25 | -13.39 |
| 2026-02-24 | -12.91 |
| 2026-02-23 | -12.43 |
| 2026-02-20 | -12.43 |
| 2026-02-19 | -12.12 |
| 2026-02-18 | -12.06 |
| 2026-02-17 | -11.60 |
| 2026-02-13 | -11.68 |
| 2026-02-12 | -11.79 |
| 2026-02-11 | -12.22 |
| 2026-02-10 | -12.52 |
| 2026-02-09 | -12.59 |
| 2026-02-06 | -12.39 |
| 2026-02-05 | -11.74 |
| 2026-02-04 | -12.28 |
| 2026-02-03 | -12.62 |
| 2026-02-02 | -12.37 |
| 2026-01-30 | -11.92 |
| 2026-01-29 | -11.98 |
| 2026-01-28 | -11.73 |
| 2026-01-27 | -12.31 |
| 2026-01-26 | -12.20 |
| 2026-01-23 | -12.41 |
| 2026-01-22 | -12.73 |
| 2026-01-21 | -12.84 |
| 2026-01-20 | -12.73 |
| 2026-01-16 | -12.57 |
| 2026-01-15 | -12.96 |
| 2026-01-14 | -13.36 |
| 2026-01-13 | -13.10 |
| 2026-01-12 | -12.81 |
| 2026-01-09 | -12.75 |
| 2026-01-08 | -13.66 |
| 2026-01-07 | -14.21 |
| 2026-01-06 | -13.95 |